Treatment Strategy and Options
At a Glance
The primary goal of treating Graham Little-Piccardi-Lassueur Syndrome (GLPLS) is to halt the progression of permanent scalp hair loss. Dermatologists use a stepped approach, starting with topical steroids and moving to oral medications or JAK inhibitors if the condition continues to spread.
Treating Graham Little-Piccardi-Lassueur Syndrome (GLPLS) is not about finding a one-time “cure,” but rather about developing a long-term strategy to protect your hair. Because the scalp hair loss involves permanent scarring, the primary goal of every treatment is to halt the progression of the disease and “freeze” it in its current state [1][2].
Think of the treatment plan as a staircase. If the first step doesn’t provide enough protection, your doctor will guide you to the next, more intensive level of care. Because GLPLS treatments alter how your immune system functions, you should expect to wait 3 to 6 months to see if a specific medication is effectively halting the inflammation [1].
The Treatment Staircase
Level 1: Topical and Local Therapy
The first line of defense focuses on calming the “fire” of active inflammation directly on the skin.
- High-Potency Corticosteroids: These creams or ointments are applied to active patches to reduce redness, scaling, and itching [3].
- Steroid Injections: Your doctor may inject a corticosteroid (like triamcinolone) directly into the edges of an active patch to deliver the medication precisely where the immune attack is strongest.
Level 2: Oral Systemic Medications
If topicals aren’t enough to stop the spread, your doctor may prescribe systemic medications that work throughout your entire body to “quiet” the immune system. Important Safety Note: These powerful medications require baseline and ongoing medical monitoring to ensure they are safe for your body.
- Hydroxychloroquine: Often used for months at a time, this medication is a common second-line choice for stabilizing the condition [4]. Monitoring: Requires regular ophthalmologic (eye) exams to prevent a rare side effect called retinal toxicity.
- Immunosuppressants: Medications like methotrexate or cyclosporine may be used to suppress the overactive T-cell response [5]. Monitoring: Requires routine blood tests to check liver and kidney function.
Level 3: Advanced and Emerging Therapies
For cases that are “recalcitrant” (meaning they don’t respond to standard treatments), newer options are showing significant promise.
- JAK Inhibitors: Drugs like tofacitinib target a specific inflammatory pathway that is highly active in GLPLS. These have demonstrated the ability to halt disease progression even in difficult cases [6][7]. Important Safety Note: JAK inhibitors carry FDA “black-box” warnings due to serious potential risks, including increased susceptibility to severe infections, cardiovascular events, thrombosis (blood clots), and certain malignancies. Starting a JAK inhibitor requires a thorough risk-benefit discussion and rigorous screening with a specialist.
- NB-UVB Phototherapy: Narrow-band ultraviolet B light therapy has been used successfully in some GLPLS patients to help control the condition without the need for systemic drugs [8].
Managing the Rest of the Triad
While saving scalp hair is often the highest priority, the other symptoms of the GLPLS triad also require management:
- Follicular Keratosis (Body Bumps): These rough, sandpaper-like bumps often improve when you start systemic medications for the scalp [9]. However, for daily comfort, your doctor can prescribe keratolytic lotions (containing urea, salicylic acid, or lactic acid) to gently dissolve the keratin plugs and smooth the skin.
- Body Hair Loss: The non-scarring loss in the armpits and groin is unpredictable. Once systemic inflammation is controlled, some patients may see this hair regrow, while for others, the follicles remain dormant indefinitely [2].
A Note on “Snake-Oil” and Hair Regrowth
It is vital to be cautious of products promising to “miraculously regrow” hair in areas of GLPLS scarring. Because the hair follicle stem cells are destroyed and replaced by scar tissue (fibrosis), standard hair growth treatments (like over-the-counter minoxidil or supplements) cannot regrow hair in those specific spots [10]. While some patients may see a small amount of regrowth if inflammation is caught very early, the focus of medical treatment remains on preservation of existing hair [11][1].
Common questions in this guide
Can treatments regrow the hair I've already lost to GLPLS?
When are oral medications like hydroxychloroquine used for GLPLS?
What are JAK inhibitors and how do they treat GLPLS?
How can I treat the rough skin bumps on my body?
How long does it take to see if a GLPLS treatment is working?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my current scalp symptoms and trichoscopy, should we start with topical treatments or move straight to systemic medications like hydroxychloroquine?
- 2.If my condition is considered 'recalcitrant' or stubborn, at what point would we discuss JAK inhibitors like tofacitinib?
- 3.Is narrow-band UVB (NB-UVB) phototherapy a viable option for my specific triad of symptoms?
- 4.How long must my disease be 'stable' before we can discuss options like hair transplantation for the scarred areas?
- 5.What specific topical exfoliants or lotions do you recommend for managing the rough bumps (follicular keratosis) on my body?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (11)
- 1
The spectrum of pediatric scarring alopecia: A retrospective review of 27 patients seen at Mayo Clinic.
Imhof RL, Cantwell HM, Proffer SL, et al.
Pediatric dermatology 2021; (38(3)):580-584 doi:10.1111/pde.14543.
PMID: 33644931 - 2
Graham-Little-Piccardi-Lassueur Syndrome with Mucosal Involvement: A Rare Case.
Polra RV, Tandel JJ, Nair PA
International journal of trichology 2023; (15(6)):251-254 doi:10.4103/ijt.ijt_88_22.
PMID: 39600425 - 3
Lichen Planus Pigmentosus Inversus: A Case Report of a Man Presenting With a Pigmented Lichenoid Axillary Inverse Dermatosis (PLAID).
Cohen PR, Erickson CP, Calame A
Cureus 2024; (16(3)):e56995 doi:10.7759/cureus.56995.
PMID: 38681353 - 4
Systemic Treatments for Lichen Planopilaris and Frontal Fibrosing Alopecia: A Retrospective Study of 315 Patients.
Willaert M, Van Dongen T, Dikrama P, et al.
Acta dermato-venereologica 2025; (105()):adv42465 doi:10.2340/actadv.v105.42465.
PMID: 40293264 - 5
Cyclosporine or methotrexate, which one is more promising in the treatment of lichen planopilaris?; A comparative clinical trial.
Fatemi Naeini F, Mohaghegh F, Jelvan M, et al.
International immunopharmacology 2020; (86()):106765 doi:10.1016/j.intimp.2020.106765.
PMID: 32674048 - 6
Efficacy and safety of tofacitinib in the treatment of adults with lichen planopilaris: A randomized placebo-controlled trial.
Mahmoudi H, Daneshpajooh M, Dadkhahfar S, et al.
International immunopharmacology 2025; (162()):115129 doi:10.1016/j.intimp.2025.115129.
PMID: 40582144 - 7
Tofacitinib for the treatment of lichen planopilaris: A case series.
Yang CC, Khanna T, Sallee B, et al.
Dermatologic therapy 2018; (31(6)):e12656 doi:10.1111/dth.12656.
PMID: 30264512 - 8
Clinical, Dermoscopic and In-Vivo Reflectance Confocal Microscopy Evaluation of a Case of Graham Little-Piccardi-Lassueur Syndrome Successfully Treated with Narrowband-UVB Phototherapy.
Arisi M, Gelmetti A, Zanca A, et al.
Dermatology and therapy 2020; (10(4)):887-892 doi:10.1007/s13555-020-00410-x.
PMID: 32533553 - 9
Graham-Little-Piccardi-Lassueur Syndrome: Report of a Chinese Case with Hair Casts.
Li X, Chen X, Zhang J, Zhou C
International journal of trichology 2020; (12(2)):97-98 doi:10.4103/ijt.ijt_27_20.
PMID: 32684685 - 10
Exploring Remission Dynamics and Prognostic Factors in Lichen Planopilaris: A Retrospective Cohort Study.
Lyakhovitsky A, Zilbermintz T, Segal Z, et al.
Dermatology (Basel, Switzerland) 2024; (240(4)):531-542 doi:10.1159/000538355.
PMID: 38574470 - 11
Hair regrowth in cicatricial alopecia: A literature review.
Poliner AD, Tosti A
The Journal of dermatology 2021; (48(8)):1113-1128 doi:10.1111/1346-8138.15902.
PMID: 33890315
This page provides educational information about GLPLS treatment strategies. Always consult your dermatologist to determine the safest and most effective treatment plan for your specific symptoms and medical history.
Get notified when new evidence is published on Graham Little-Piccardi-Lassueur syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.